Linda Mileshkin

33.5k citations
276 papers · 6.8k · 3 hit papers · h-index 41

Impact in

    • Endometrial and Cervical Cancer Treatments
  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • Cancer Diagnosis and Treatment
    • Cancer survivorship and care
    • PARP inhibition in cancer therapy

Papers in

    • Cancer Diagnosis and Treatment 31
    • PARP inhibition in cancer therapy 21
    • Cancer survivorship and care 18
    • Cancer Immunotherapy and Biomarkers 12
    • Endometrial and Cervical Cancer Treatments 57

Linda Mileshkin

265 papers receiving 6.7k citations

Linda Mileshkin's Hit Papers

Pembrolizumab in Patients With Microsatellite Instability–High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study 2022 · 296 citations
2960+3+7Years since publication250500750

Peers

Linda Mileshkin
Comparison fields: 5 of 127
  • Obstetrics and Gynecology 1.4k
  • Oncology 2.6k
  • Reproductive Medicine 793
  • Cancer Research 724
  • Hematology 470
Replace Timothy Perren with:
Timothy Perren United Kingdom
Claire F. Verschraegen United States
Andreas Obermair Australia
Lukas Hefler Austria
R. Kreienberg Germany
Alexander Reinthaller Austria
S. Diane Yamada United States
Gloria Broadwater United States
Sërgio Pecorelli Italy
Suzanne George United States
Linda Mileshkin relative to Timothy Perren United Kingdom Timothy Perren's profile →
Citations per field
00.5×3.8×
Timothy Perren · 1×
Citations per year

Countries citing papers authored by Linda Mileshkin

Since Specialization
Citations

This map shows the geographic impact of Linda Mileshkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Mileshkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Mileshkin more than expected).

Fields of papers citing papers by Linda Mileshkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda Mileshkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Mileshkin. The network helps show where Linda Mileshkin may publish in the future.

Co-authors

The 25 scholars most cited alongside Linda Mileshkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Linda Mileshkin Line = papers co-authored together Linda Mileshkin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 276 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Cervical cancer: A global health crisis
Hit paper breakdown →
2017864
2
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
Hit paper breakdown →
2015351
3
Pembrolizumab in Patients With Microsatellite Instability–High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study
Hit paper breakdown →
2022296
4 2012198
5 2006154
6 2013131
7 2016109
8 2011106
9 2016105
10 2003105
11 2016104
12 202097
13 201394
14 201993
15 201487
16 202182
17 202282
18 201376
19 202072
20 201971

About Linda Mileshkin

Linda Mileshkin is a scholar working on Oncology, Obstetrics and Gynecology, Cancer Research, Reproductive Medicine and Pulmonary and Respiratory Medicine, having authored 276 papers that have together received 6.8k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (57 papers), Ovarian cancer diagnosis and treatment (32 papers), Cancer Diagnosis and Treatment (31 papers), Cancer Genomics and Diagnostics (25 papers), PARP inhibition in cancer therapy (21 papers), Cancer survivorship and care (18 papers), Multiple Myeloma Research and Treatments (14 papers) and Cancer Immunotherapy and Biomarkers (12 papers). The work is most often cited by research in Obstetrics and Gynecology (1.4k citations), Oncology (2.6k citations), Reproductive Medicine (793 citations), Cancer Research (724 citations) and Hematology (470 citations). Linda Mileshkin has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Henry C Kitchener, H. Miles Prince, William Small, Akila N. Viswanathan, David K. Gaffney, Monica Bacon, Amishi Bajaj, Anuja Jhingran, Matthew M. Harkenrider and Linus Chuang. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, International Journal of Gynecological Cancer, Gynecologic Oncology and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact